MA CRO/CMO Symposium: Accelerating Drug Development

Tuesday, March 6 2012
7:30 am – 4:00 pm

Agenda

Download Agenda

 

7:30:     Continental Breakfast                   Sponsored by Bionostics

Registration, Networking and Refreshments

8:30:     Welcome & Logistical Remarks

  • Shelley Amster, CRO/CMO Committee, Conference Co-Chair

             MA CRO CMO Committee Historical Background

  • Ed Price, CEO, PCI Synthesis           

             Opening Remarks

  • Raj Rajur, Ph.D., Founder, President and CEO, Creagen Biosciences, Conference Co-Chair

             Keynote Presentation                                 

  • Josef H. von Rickenbach, Chair of the Board, CEO and Founder of PAREXEL International

9:15:     Regulatory Inspection Trends

  • Karen N. Archdeacon, Compliance Officer, FDA New England District

 9:45:    Networking and Refreshment Break in Exhibit Area

10:30    The Changing Paradigm – Reality from the Front Office

Moderator and Panelists:

  • Roger Frechette, Ph.D. Co-Founder & CSO, NE Pharma Associates - Moderator
  • Peter Lanciano, CEO, Neotropix
  • Yael Schwartz, Ph.D., CEO & President, Hygeia Therapeutics
  • Walter Olgier, CEO, Acetylon
  • Leslie Williams, President & CEO, ImmusanT, Inc.

11:15:   Collaboration Drives R & D - Working Together

Moderator and Panelists:

  • Norton Peet, Ph.D., Director of Chemistry, Microbiotix, Inc. - Moderator
  • Barbara Fox, Ph.D., CEO, Avaxia Biologics
  • Ross D. Pettit, Ph.D., VP of Clinical Ops & Outsourcing, AMAG Pharmaceuticals, 
  • Craig M. Sorensen, Ph.D., VP R&D Network Design & Technology Integration, Vertex
  • Murali Gopalakrishnan, Ph.D., Director of Global External Research, Abbott Laboratories       

12:00:   Networking Luncheon Buffet in Exhibit Halls                    

1:15:     Keynote Presentation: Job Creation in This Economic Climate

  • Timothy Murray, Lieutenant Governor of Massachusetts (confirmed)               

1:30:     The Evolving VC World & Their Growing Relationships with External Resources

Moderator & Panelists

  • Daniel Behr, MBA, Founder, Access BridgeGap Ventures Access Industries, Inc.
  • Kevin Bitterman, Principal, Polaris Ventures
  • Bernat Olle, Ph.D., Principal, PureTech Ventures
  • Douglas E. Onsi, Managing Director, HealthCare Ventures
  • Chris Velis, Principal, Medcap Advisors

2:15:     CRO CMO Innovation Showcase                

  • Marc Bazin, CEO and Co-Founder, HepatoChem
  • Deborah J. Moshinsky, Ph.D., President and CSO, Cell Assay Innovations, LLC
  • Joel Berniac, Ph.D., MBA, President, CEO/Co-Founder, Akrivis Technologies, LLC

3:00       Partnerships and Funding Alternative Resources                   

Moderator & Panelists: 

  • Doug Banks, Associate VP for Economic Development, University of Massachusetts - Moderator
  • Betsy M. Ohlsson-Wilhelm, Ph.D., CEO, SciGro, Inc.
  • Martha Farmer, Ph.D., President & CEO, North Shore InnoVentures
  • Richard D. Gill, Ph.D., President & CEO, TruTouch Technologies, LaunchPad Venture Group                                 
  • Pamela Norton, VP, Industry and Program Relations, Massachusetts Life Sciences Center  

3:45:     Closing Remarks

  • Scott Gillis, CEO, Onsite Therapeutics, Inc. and Board Member, MassBio 

4:00:     Program Adjourns. Networking Reception Begins.

Reception sponsored by:   PCI                                                                                                            

ORGANIZATION STEERING COMMITTEE

Avecia Biotechnology

Averica Discovery

Biotrofix, Inc.

Blue Sky BioServices

Blue Stream Laboratories

Cambridge Biomedical

Ce3inc

CreaGen Biosciences

Microtest Laboratories, Inc.

NSF Pharmalytica

ORA Clinical

Organix, Inc.

 

PCI

PION INC

Pharmalucence, Inc.

SBH Sciences

TGA Sciences, Inc.

ViviSource Laboratories

Xtal Biostructures

SPECIAL THANK YOU TO THE SPONSORS THAT ARE MAKING THIS EVENT POSSIBLE:

MHT      MLSC      PCI   Bionostics

SPECIAL THANKS TO OUR OTHER MA CRO CMO EXHIBITORS THAT ARE MAKING THIS EVENT POSSIBLE

Agilux

Akrivis Technologies

Associates of Cape Cod, Inc.

BIOMODELS

Bionostics

CBSET, Inc.

Cell Assay Innovations

Court Square Group

eClinical Solutions, a Division of Eliassen Group

Ekam Imaging

HepatoChem

Johnson Matthey Pharma Services

Luria Scientific Industries

Neo-Advent Technologies

Neuroscience Discovery Core

ProMedica CRC

Safety Partners, Inc.

WingU

 


Share MassBio

 

BioProcess

EvaluatePharma 

MassBio